STAND. COM. REP. NO. 1359-00

                                 Honolulu, Hawaii
                                                   , 2000

                                 RE: S.B. No. 2254
                                     S.D. 1
                                     H.D. 2




Honorable Calvin K.Y. Say
Speaker, House of Representatives
Twentieth State Legislature
Regular Session of 2000
State of Hawaii

Sir:

     Your Committees on Consumer Protection and Commerce and
Judiciary and Hawaiian Affairs, to which was referred S.B. No.
2254, S.D. 1, H.D. 1, entitled: 

     "A BILL FOR AN ACT RELATING TO PRIVACY OF HEALTH CARE
     INFORMATION,"

beg leave to report as follows:

     The purpose of this measure is to facilitate patient care
within a health care setting by clarifying that notification
requirements do not apply to the use or disclosure of protected
health information within an entity.

     Testimony in support of this measure was submitted by Hawaii
Medical Service Association and the American Family Life
Assurance Company of Columbus.

     Testimony in support of this measure, with proposed
amendments, was submitted by the Hawaii Medical Association,
Healthcare Association of Hawaii, Pharmaceutical Research and
Manufacturers of America, Glaxo Wellcome Inc., and the Patient
Records Confidentiality Task Force.

     Testimony supporting this measure in part and opposing it in
part was submitted by the Office of Information Practices and
Kaiser Permanente.


 
 
 
                                 STAND. COM. REP. NO. 1359-00
                                 Page 2

 
     Testimony in opposition to this measure was submitted by the
Coalition to Protect Privacy, a physician, and a concerned
citizen.

     Your Committees have made the following amendments to this
bill:

     (1)  Revised subsection 323C-37(c), Hawaii Revised Statutes,
          to incorporate the amendments proposed by the Patient
          Records Confidentiality Task Force;

     (2)  Incorporated the amendments proposed by the
          Pharmaceutical Research and Manufacturers of America
          and Glaxo Wellcome Inc.;

     (3)  Revised the effective date for criminal and civil
          penalties of Act 87, Session Laws of Hawaii 1999, to
          January 1, 2001; and

     (4)  Incorporated technical, nonsubstantive amendments for
          purposes of clarity, consistency, and style.

     As affirmed by the records of votes of the members of your
Committees on Consumer Protection and Commerce and Judiciary and
Hawaiian Affairs that are attached to this report, your
Committees are in accord with the intent and purpose of S.B. No.
2254, S.D. 1, H.D. 1, as amended herein, and recommend that it
pass Third Reading in the form attached hereto as S.B. No. 2254,
S.D. 1, H.D. 2.

                                   Respectfully submitted on
                                   behalf of the members of the
                                   Committees on Consumer
                                   Protection and Commerce and
                                   Judiciary and Hawaiian
                                   Affairs,

                                   
                                   
                                   
                                   
______________________________     ______________________________
ERIC G. HAMAKAWA, Chair            RON MENOR, Chair